Literature DB >> 27278059

[Pharmacological prophylactic treatment for relapse of alcohol dependence : Results of current meta-analyses].

J Mutschler1,2, M Soyka3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27278059     DOI： 10.1007/s00115-016-0133-x

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  44 in total

1.  Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome.

Authors:  Henning Krampe; Sabina Stawicki; Thilo Wagner; Claudia Bartels; Carlotta Aust; Eckart Rüther; Wolfgang Poser; Hannelore Ehrenreich
Journal:  Alcohol Clin Exp Res       Date:  2006-01       Impact factor: 3.455

2.  Efficacy of baclofen on abstinence and craving in alcohol-dependent patients: a meta-analysis of randomized controlled trials.

Authors:  Nicolas Lesouef; Florelle Bellet; Geneviève Mounier; Marie-Noëlle Beyens
Journal:  Therapie       Date:  2014-09-18       Impact factor: 2.070

3.  A meta-analysis of topiramate's effects for individuals with alcohol use disorders.

Authors:  Janet C Blodgett; A C Del Re; Natalya C Maisel; John W Finney
Journal:  Alcohol Clin Exp Res       Date:  2014-05-05       Impact factor: 3.455

4.  Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging.

Authors:  Karl Mann; Sabine Vollstädt-Klein; Iris Reinhard; Tagrid Leménager; Mira Fauth-Bühler; Derik Hermann; Sabine Hoffmann; Ulrich S Zimmermann; Falk Kiefer; Andreas Heinz; Michael N Smolka
Journal:  Alcohol Clin Exp Res       Date:  2014-11       Impact factor: 3.455

5.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

Authors:  Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben
Journal:  JAMA       Date:  2006-05-03       Impact factor: 56.272

6.  Effects of naltrexone on cortisol levels in heavy drinkers.

Authors:  Lara A Ray; James Mackillop; Lorenzo Leggio; Marilee Morgan; Kent E Hutchison
Journal:  Pharmacol Biochem Behav       Date:  2008-09-13       Impact factor: 3.533

7.  Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.

Authors:  M Soyka; M Friede; J Schnitker
Journal:  Pharmacopsychiatry       Date:  2016-02-04       Impact factor: 5.788

8.  Naltrexone effects on cortisol secretion in women and men in relation to a family history of alcoholism: studies from the Oklahoma Family Health Patterns Project.

Authors:  William R Lovallo; Andrea C King; Noha H Farag; Kristen H Sorocco; Andrew J Cohoon; Andrea S Vincent
Journal:  Psychoneuroendocrinology       Date:  2012-05-08       Impact factor: 4.905

9.  An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.

Authors:  Raymond F Anton; Gabor Oroszi; Stephanie O'Malley; David Couper; Robert Swift; Helen Pettinati; David Goldman
Journal:  Arch Gen Psychiatry       Date:  2008-02

Review 10.  The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.

Authors:  Kim Donoghue; Catherine Elzerbi; Rob Saunders; Craig Whittington; Stephen Pilling; Colin Drummond
Journal:  Addiction       Date:  2015-03-17       Impact factor: 6.526
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.